Category Archives: Public Policy

Latest From Public Policy

JOBS Act Deconstructed: Regulation A

More than 40 biotech companies have gone public using provisions made available to emerging growth companies through the JOBS Act.  BIOtechNOW’s JOBS Act Deconstructed series will explore why it has had such an impact on biotech offerings and how emerging companies can leverage the new law to their best advantage. In a nutshell: The JOBS Act directs the SEC to create a new class of securities modeled after those eligible for the existing exemption under SEC Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

flags with blue sky

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits the United States provides to countries that disrespect intellectual property rights.  On September 20, 2013, Representative Terry introduced the “Playing Fair on Trade and Innovation Act.”  The Bill would deem countries ineligible for the Generalized System of Preferences program (GSP) if that country “fails to provide adequate and effective protection for intellectual property rights” or “maintains local content requirements…”  GSP Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

“Should the USPTO allow the patenting of living organisms?”

shutterstock_1092009

Most people associate patents with mechanical or electronic devices, new chemical substances, intricate machines or other inanimate things. The notion that patents are also available for living things may be puzzling at first. A patent is a form of property right that allows its owner a certain measure of control over how others may make, use or sell the patented invention. Surely the inventor of e.g. a new gyroscope sensor (like those used in Segway Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , ,

India’s IP Policy: India’s Lead Biotech Innovator Expresses Concern

shutterstock_2103563

Kiran Mazumdar-Shaw, chairperson and managing director of India’s largest biotechnology company Biocon, expressed concern with India’s innovation environment in a recent interview with Livemint.  When asked if the Indian government fosters innovation Ms. Shaw responded: “I am very concerned about the wrong signals we are sending to the world. We have not done anything substantial to build India as a strong global economy. We have wasted a lot of opportunities. We behave like the world Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Patent Trolls and Patent Litigation: The GAO Weighs In

shutterstock_26191726

Patent troll litigation alarmist were likely disappointed by the GAO report.  While the public discourse may have already concluded that patent trolls have laid waste to the innovative landscape by creating a patent litigation crisis, the GAO report does not find much evidence to support such claims. Patent troll litigation is not running rampant.  The GAO analyzed a sample of 500 patent infringement lawsuits from 2007 to 2011 and found that companies that make products (operating Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,